Possessing considerable experience in the field of health care and medical products, Patrick Ridgeway is a biotechnology entrepreneur based in New Orleans. Over the course of his career, Patrick Ridgeway has focused largely on issues related to women’s health and pharmacogenetics. In addition, he maintains an interest in adverse drug reactions and the cost they impose on health care delivery.
According to the Food and Drug Administration, adverse drug reactions cost a total of $136 billion every year, which is more than the total costs for both diabetic and cardiovascular care. After an adverse drug reaction, patients tend to stay in the hospital twice as long as control patients, and they face much higher risk of death.
According to a meta-analysis of studies looking at adverse drug reactions, more than half of them are preventable in the outpatient setting. The paper found that about 2 percent of adult outpatients experience an adverse drug reaction and 52 percent of these reactions were preventable. Among inpatients, nearly half of all adverse drug reactions were preventable.
These findings suggest that more research needs to be done on how to prevent adverse drug interactions more effectively and relieve some of the financial burden it puts on the health care system, not to mention the physical burden on patients themselves.
Comments
Post a Comment